Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 23, 2020 07:55 ET | Source: Guardant Health, Inc.

Guardant Health Launches Real-World Clinical-Genomic Platform to Accelerate Precision Oncology Drug Development

REDWOOD CITY, Calif., June 23, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, addresses the challenges of developing new precision oncology...
June 22, 2020 09:05 ET | Source: Guardant Health, Inc.

Guardant Health Presents Data at AACR Virtual Annual Meeting II Showing Liquid Biopsy Highly Accurate in Detecting Early-Stage Colorectal Cancer

REDWOOD CITY, Calif., June 22, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, presents new data at the American Association for Cancer Research...
June 16, 2020 16:30 ET | Source: Guardant Health, Inc.

Guardant Health Appoints Vijaya Gadde to its Board of Directors

REDWOOD CITY, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has appointed Vijaya Gadde to serve on its Board of Directors. ...
June 08, 2020 16:03 ET | Source: Guardant Health, Inc.

Guardant Health Announces Full Exercise of Option and Closing of Public Offering

REDWOOD CITY, Calif., June 08, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) (“Guardant Health”), a leading precision oncology company focused on helping conquer cancer globally...
June 01, 2020 22:32 ET | Source: Guardant Health, Inc.

Guardant Health Announces Pricing of Upsized Public Offering

REDWOOD CITY, Calif., June 01, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) (“Guardant Health”), a leading precision oncology company focused on helping conquer cancer globally...
June 01, 2020 16:37 ET | Source: Guardant Health, Inc.

Guardant Health Announces Proposed Public Offering of Common Stock

REDWOOD CITY, Calif., June 01, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) (“Guardant Health”), a leading precision oncology company focused on helping conquer cancer globally...
May 29, 2020 16:03 ET | Source: Guardant Health, Inc.

Guardant Health to Participate in the William Blair 2020 Growth Stock Conference

REDWOOD CITY, Calif., May 29, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the upcoming William Blair Virtual Growth Stock...
May 15, 2020 08:05 ET | Source: Guardant Health, Inc.

Guardant Health Data at ASCO and AACR Demonstrates Growing Value of Liquid Biopsy for Precision Oncology in Advanced and Early Stage Cancer

REDWOOD CITY, Calif., May 15, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) along with leading academic institutions and pharmaceutical companies will present data highlighting the use...
May 07, 2020 16:03 ET | Source: Guardant Health, Inc.

Guardant Health Reports First Quarter 2020 Financial Results

REDWOOD CITY, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its...
May 06, 2020 16:03 ET | Source: Guardant Health, Inc.

Guardant Health to Participate in the BofA Securities 2020 Healthcare Conference

REDWOOD CITY, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the upcoming BofA Securities Virtual Healthcare...